We’re excited to share a groundbreaking partnership with the Accelerated Cure Project (ACP)—a leading non-profit dedicated to improving multiple sclerosis (MS) diagnosis and treatment.

Why This is a Game-Changer

🧬 MS affects nearly 3 million people worldwide—yet diagnosis and treatments are still not optimized.

💡 Current research is limited by high costs and outdated methods.

 ⚡ Biostate AI is changing that.

Through this collaboration, we will sequence RNA from 100 MS clinical samples provided by ACP using our proprietary BIRT RNASeq technology—at 5X lower cost than existing methods.

This means:

✅ Faster research progress toward better MS treatments.

✅ Breakthrough discoveries that weren’t possible before.

✅ A real-world demonstration of Biostate AI’s competitive edge.

What’s Next?

This is just the beginning. We’re building toward a future where millions of clinical samples can be sequenced at scale, unlocking new medical breakthroughs in countless diseases.

Want to be part of this revolution?

🔴 Invest now before this opportunity closes!

The next update will reveal how our AI-powered approach is uncovering patterns never seen before in MS research. Stay tuned! 🚀